Dose-intensive chemotherapy in extensive-stage small-cell lung cancer

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 40, Issue , 1997, Pages

  Negoro, Shunichi ^a   Masuda, Noriyuki ^b   Furuse, Kiyoyuki ^c   Saijo, Nagahiro ^d   Fukuoka, Masahiro ^e  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CODE chemotherapy; Dose intensity; Extensive stage small cell lung cancer; rhG CSF

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; CANCER STAGING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

EID: 0030738678     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051065     Document Type: Conference Paper

References (12)

1. Aisner J (1996) Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat. J Clin Oncol 14:658
2. Aisner J, Alberto P, Bitran J, Comis R, Daniels J, Hansen H, Ikegami H, Smyth J (1983) Role of chemotherapy in small-cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. Cancer Treat Rep 67:37
3. Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM (1987) Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small-cell lung cancer. Br J Cancer 56:809
4. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy J (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164
5. Frei E, Canellos GP (1980) Dose: a critical factor in cancer chemotherapy. Am J Med 69:585
6. Fukuoka M, Masuda N, Takada M, Kodama N, Kawahara M, Furuse K (1994) Dose-intensive chemotherapy in extensive-stage small-cell lung cancer. Semin Oncol 21:43
7. Fukuoka M, Masuda M, Negoro S, Matsui K, Yana T, Kudoh S, Kusunoki Y, Takada M, Kawahara M, Ogawara M, Kodama N, Kubota K, Furuse K (1997) CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. Br J Cancer 75:306
8. Furuse K, Kubota K, Nishiwaki Y, Takada M, Kurita Y, Watanabe K, Noda K, Fukuoka M, Ariyoshi H, Osaki Y, Tamura H, Saijo N, for the Japan Lung Cancer Study Group (1996) Phase III study of dose intensive weekly chemotherapy with recombinant human granulocyte-colony stimulating factor (G-CSF) versus standard chemotherapy in extensive stage small-cell lung cancer (SCLC). Proc Am Soc Clin Oncol 15:375
9. Masuda N, Fukuoka M, Furuse K (1992) CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive-stage small-cell lung cancer. Oncology 1:19
10. Miles DW, Fogarty O, Ash CM, Rudd RM, Trask CW, Spiro SG, Gregory WM, Ledermann JA, Souhami RL, Harper PG (1994) Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. J Clin Oncol 12:77
11. Murray N, Shah A, Osoba D, Page R, Karsai H, Grafton C, Goddard K, Fairey R, Voss N (1991) Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer. J Clin Oncol 9:1632
12. Trillet-Lenoir V, Green J, Manegold C, Von Pawel J, Gatzemeier U, Lebeau B, Depierre A, Johnson P, Decoster G, Tomita D, Ewen C (1993) Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 29A:319